Bioethics Experts Announce Global Research Platform To Tackle Ethical, Legal And Social Issues In Genomics

Source : Indiana University

INDIANAPOLIS -- Just as the sequencing of the human genome is having a pervasive and global impact on medicine, work on the societal impact of the genomic revolution must also move to an international stage, a team of bioethics experts said today.

Writing in the online publication of the journal Science, the group, including Indiana University bioethicist Eric M. Meslin, Ph.D., announced the creation of ELSI 2.0, an international “collaboratory” to better respond to the global aspects of the ethical, legal and social implications (ELSI) of modern genomics.

The human genome project began with mapping and then sequencing the genes that make up human DNA, and the original ELSI program of the genome project did much the same thing:  “mapping” broad issues such as genetic discrimination and then “sequencing” the individual components such as genetic discrimination in insurance, housing and education, said Dr. Meslin, director of the Indiana University Center for Bioethics and associate dean for bioethics in the Indiana University School of Medicine. Now, he said, ELSI research needs to move to the next level, to better understand how to ensure greater impact from research and how to design better policies.

“Society can benefit from the ELSI research being undertaken globally. The issues, the problems, the questions are no longer the province of a small group of ELSI researchers in a handful of countries,” Dr. Meslin said. “There are many genomics research initiatives worldwide, and now there are ELSI initiatives to match them. It’s time to leverage this amazing resource.”

The goal of ELSI 2.0 is to accelerate the translation of ELSI research findings into practice and policy, the authors wrote: “Through ELSI 2.0, ELSI researchers can be globally connected while still carrying out locally sensitive research.” 

Hosted at the P3G Consortium in Montreal, Canada, ELSI 2.0 will be a Web-based initiative taking advantage of many new collaborative research tools such as webinars and crowd-sourcing to provide access to the world’s ELSI research, so scientists can build on, not repeat, research done somewhere. 

“The traditional model in which you do research, write it up and hope someone notices is no longer the only way, or the most effective way, to do research,” Dr. Meslin said. 

Also envisioned is the ability to create “rapid response” teams that would quickly respond to events, such as pending legislation, much like the world’s scientific community was able to quickly sequence the structure of the virus responsible for severe acute respiratory syndrome in 2003.

In addition to Dr. Meslin, the authors of the Science statement are Jane Kaye of the University of Oxford, United Kingdom; Bartha M. Knoppers of McGill University, Montreal, Canada; Eric Juengst of the University of North Carolina; Mylene Deschenes of the P3G Consortium; Anne Cambon-Thomsen of the University Paul Sabatier, Toulouse, France; Donald Chalmers of the University of Tasmania, Australia; Jantina De Vries of the University of Cape Town, South Africa; Kelly Edwards of the University of Washington; Nils Hoppe of Leibniz Universität, Germany; Alastair Kent of the Genetic Alliance UK, United Kingdom; Clement Adebamowo of the Institute of Human Virology, Nigeria; Patricia Marshall of Case Western Reserve University; and Kazuto Kato of Osaka University, Japan.

  • <<
  • >>

Articles List

  • Seeking a Happy (Cell Culture) Medium

    Seeking a Happy (Cell Culture) Medium

    Cell lines have been a staple of medical research at least since Henrietta Lacks’ ovarian tumor became HeLa cells more than half a century ago. Today, culturing continuous, immortalized cells is relatively routine—just take a bottle of medium off the shelf, throw in some serum (if it’s not already in there), add it to a flask and keep it cozy in a CO2 incubator. Primary cells and stem cells, on the other hand, are fussier. They have a limited life span, need a special blend of factors to grow and are susceptible to other factors that can take them down an undesired differentiation pathway. Here we look at some of the media researchers use to keep such finicky cells happy.
  • More than One Way to Change a Base

    More than One Way to Change a Base

    It’s easier than ever these days to clone and sequence DNA. Thanks to CRISPR/Cas and related technologies, it’s even straightforward to rewrite genomic sequences in living cells and organisms. But as powerful as it is, CRISPR, et al., cannot induce genetic rewrites in a test tube—genome editing requires cellular machinery to repair the DNA breaks the methods produce. Instead, researchers interested in mutating cloned genes on plasmids must revert to a tried-and-true method, site-directed mutagenesis. First described in the 1970s—and earning its inventor a share of the Nobel Prize in Chemistry in 1993—site-directed mutagenesis uses short oligonucleotides to introduce single base changes, as well as insertions and deletions, to DNA plasmids. Researchers can use the method to swap amino acids in expressed proteins, test clinically relevant mutations and tweak promoters. But there’s more than one way to change a base, and molecular-tools vendors have commercialized multiple strategies. Here, we review some of the more popular approaches to site-directed mutagenesis.

Disqus Comments